Shandong Wohua Pharmaceutical Co., Ltd.

Equities

002107

CNE000001QB8

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-09 pm EDT 5-day change 1st Jan Change
4.99 CNY -1.77% Intraday chart for Shandong Wohua Pharmaceutical Co., Ltd. +3.53% -17.79%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Shandong Wohua Pharmaceutical Co., Ltd. Proposes Profit Distribution for 2023 CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Wohua Pharmaceutical Sets Payment Date For 2021 Final Dividend MT
Shandong Wohua Pharmaceutical Co., Ltd. Approves Dividend for the Year 2021, Payable on March 8, 2022 CI
Shandong Wohua Pharmaceutical Co., Ltd. Announces Executive Appointments CI
Wohua Pharmaceutical Declares Final 2021 Dividend MT
Shandong Wohua Pharmaceutical Co., Ltd. Proposes Dividend for the Year 2021 CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Shandong Wohua Pharmaceutical Co., Ltd. Declares Cash Dividend for A Shares for 2020, Payable on 09 April 2021 CI
Beijing Tongfengtang Pharmaceutical Management Co., Ltd. cancelled the acquisition of Wohua Pharmaceutical International Co., Ltd. from Shandong Wohua Pharmaceutical Co., Ltd.. CI
Shandong Wohua Pharmaceutical Co., Ltd. Approves Distribution for 2020 CI
Shandong Wohua Pharmaceutical : Pharma Declares Cash Dividend MT
Shandong Wohua Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2020 CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
Chart Shandong Wohua Pharmaceutical Co., Ltd.
More charts
Shandong Wohua Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, production and distribution of Chinese traditional patent medicines. The Company's main products consist of Xinkeshu tablets for the treatment of coronary heart disease; Gushu tablets for the treatment of middle-aged and senile osteoporosis, and Hedan tablets for promoting blood circulation and for the treatment of hyperlipidemia. The Company distributes its products in domestic market, mainly in East China, North China and Northeast China.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 002107 Stock
  4. News Shandong Wohua Pharmaceutical Co., Ltd.
  5. Shandong Wohua Pharmaceutical : Pharma Declares Cash Dividend
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW